Back to top
more

PetMed Express (PETS)

(Real Time Quote from BATS)

$3.21 USD

3.21
13,568

-0.03 (-0.93%)

Updated Aug 4, 2025 09:58 AM ET

Zacks Rank:

This is our short term rating system that serves as a timeliness indicator for stocks over the next 1 to 3 months. How good is it? See rankings and related performance below.

Zacks Rank Definition Annualized Return
1Strong Buy23.75%
2Buy17.82%
3Hold9.58%
4Sell5.28%
5Strong Sell2.61%
S&P50011.30%

Zacks Rank Education - Learn about the Zacks Rank

Zacks Rank Home - Zacks Rank resources in one place

Zacks Premium - The only way to fully access the Zacks Rank

5-Strong Sell of 5         5

Style Scores:

The Style Scores are a complementary set of indicators to use alongside the Zacks Rank. It allows the user to better focus on the stocks that are the best fit for his or her personal trading style.

The scores are based on the trading styles of Value, Growth, and Momentum. There's also a VGM Score ('V' for Value, 'G' for Growth and 'M' for Momentum), which combines the weighted average of the individual style scores into one score.

  • Value Score A
  • Growth Score A
  • Momentum Score A
  • VGM Score A

Within each Score, stocks are graded into five groups: A, B, C, D and F. As you might remember from your school days, an A, is better than a B; a B is better than a C; a C is better than a D; and a D is better than an F.

As an investor, you want to buy stocks with the highest probability of success. That means you want to buy stocks with a Zacks Rank #1 or #2, Strong Buy or Buy, which also has a Score of an A or a B in your personal trading style.

Zacks Style Scores Education - Learn more about the Zacks Style Scores

D Value B Growth D Momentum C VGM

Industry Rank:

The Zacks Industry Rank assigns a rating to each of the 265 X (Expanded) Industries based on their average Zacks Rank.

An industry with a larger percentage of Zacks Rank #1's and #2's will have a better average Zacks Rank than one with a larger percentage of Zacks Rank #4's and #5's.

The industry with the best average Zacks Rank would be considered the top industry (1 out of 265), which would place it in the top 1% of Zacks Ranked Industries. The industry with the worst average Zacks Rank (265 out of 265) would place in the bottom 1%.

Zacks Rank Education -- Learn more about the Zacks Rank
Zacks Industry Rank Education -- Learn more about the Zacks Industry Rank

Bottom 38% (153 out of 246)

Industry: Internet - Commerce

Zacks Premium FeatureView All Zacks #1 Ranked Stocks

Zacks News

Zacks Equity Research

JD.com (JD) Q4 Earnings Miss Estimates, Revenues Improve Y/Y

by Zacks Equity Research

JD.com's (JD) fourth-quarter earnings are impacted by higher spending in growth areas including fulfillment centers and increasing competition from Alibaba.

    Zacks Equity Research

    Bio-Rad (BIO) Q4 Earnings Improve Y/Y, Revenues Top Mark

    by Zacks Equity Research

    Bio-Rad's (BIO) strong sales in Q4 ride high on a robust performance at Life Science product lines.

      Zacks Equity Research

      OPKO Health (OPK) Q4 Earnings Decline Y/Y, Margins Down

      by Zacks Equity Research

      OPKO Health (OPK) posts lackluster Q4 numbers due to rising operating expenses owing to investments associated with the launch of RAYALDEE and consistent investments in the pharmaceutical pipeline.

        Zacks Equity Research

        DENTSPLY (XRAY) Earnings and Revenues Beat Estimates in Q4

        by Zacks Equity Research

        Strong performance at Dental & Healthcare Consumables segment drives DENTSPLY's (XRAY) Q4 sales.

          Zacks Equity Research

          Patterson Companies (PDCO) Misses on Q3 Earnings, Cuts View

          by Zacks Equity Research

          Lower sales and gross-margin compression mars Patterson Companies' (PDCO) results in Q3.

            Zacks Equity Research

            Alarm.com (ALRM) Q4 Earnings Top Estimates, Issues 2018 View

            by Zacks Equity Research

            Alarm.com (ALRM) reports strong fourth-quarter results on the back of higher SaaS and license revenues, and portfolio expansion.

              Zacks Equity Research

              Masimo (MASI) Beats on Q4 Earnings & Revenues, View Positive

              by Zacks Equity Research

              Strong performance in Product revenues drove Masimo's (MASI) fourth-quarter 2017 results.

                Zacks Equity Research

                DexCom (DXCM) Surpasses Earnings & Revenue Estimates in Q4

                by Zacks Equity Research

                DexCom (DXCM) rides high on strength in all segments in Q4.

                  Zacks Equity Research

                  Wright Medical (WMGI) Beats Q4 Earnings & Revenue Estimates

                  by Zacks Equity Research

                  Wright Medical (WMGI) delivers promising Q4 results on the back of strength in its flagship Upper Extremities segment, despite declining international revenues of the Lower Extremities.

                    Zacks Equity Research

                    Amedisys (AMED) Q4 Earnings Miss, Revenues Beat Estimates

                    by Zacks Equity Research

                    Amedisys (AMED) registers strong growth across all segments in Q4.

                      Zacks Equity Research

                      Penumbra (PEN) Posts Earnings in Q4, Revenues Top Estimates

                      by Zacks Equity Research

                      Penumbra (PEN) sees strong growth across all geographical regions and product lines in Q4.

                        Zacks Equity Research

                        Inogen (INGN) Beats Earnings and Revenue Estimates in Q4

                        by Zacks Equity Research

                        Inogen (INGN) reports impressive Q4 financial results on the back of strong business-to-business and direct-to-consumer sales growth.

                          Zacks Equity Research

                          Integra LifeSciences (IART) Beats on Q4 Earnings & Revenues

                          by Zacks Equity Research

                          Integra LifeSciences's (IART) solid Q4 revenue growth was primarily driven by high organic revenues and better-than-expected performance by the recently-acquired businesses.

                            Zacks Equity Research

                            Booking Holdings (BKNG) Beats on Q4 Earnings & Revenues

                            by Zacks Equity Research

                            Booking Holdings' (BKNG) fourth-quarter results are driven by significant contributions from investments in people, systems and marketing.

                              Zacks Equity Research

                              Fitbit (FIT) Q4 Loss Greater Than Estimated, Revenues Miss

                              by Zacks Equity Research

                              Fitbit's (FIT) fourth-quarter 2017 results are impacted by weak demand for its fitness products.

                                Zacks Equity Research

                                NuVasive (NUVA) Meets Q4 Earnings Estimates, Issues '18 View

                                by Zacks Equity Research

                                NuVasive (NUVA) gains on continued growth in international business in Q4.

                                  Zacks Equity Research

                                  PetMed (PET) Focuses on Advertising to Boost New Order Sales

                                  by Zacks Equity Research

                                  PetMed (PETS) implements several strategies to revitalize top line.

                                    Zacks Equity Research

                                    GoDaddy (GDDY) Beats Earnings & Revenue Estimates in Q4

                                    by Zacks Equity Research

                                    GoDaddy (GDDY) reports strong fourth-quarter revenues on the back of growth in customers, new products and contribution from HEG acquisition.

                                      Ryan McQueeney headshot

                                      After Wayfair's Earnings Miss, Buy These E-Commerce Stocks Instead

                                      by Ryan McQueeney

                                      Shares of Wayfair (W) were down more than 17% in early morning trading Thursday after the e-commerce company posted a wider-than-expected fourth-quarter loss. For investors who would rather focus on e-commerce stocks that have recently posted positive earnings surprises, there are plenty of options elsewhere.

                                        Ryan McQueeney headshot

                                        3 Retail Stocks That Crushed Earnings Estimates This Season

                                        by Ryan McQueeney

                                        The holiday season has the potential to make or break of retailer's fiscal year. Now that we are on the other side of the bulk of Q4's earnings announcements, we can see that several notable companies performed particularly well.

                                          Zacks Equity Research

                                          Garmin (GRMN) Q4 Earnings Beat Estimates, Issues 2018 View

                                          by Zacks Equity Research

                                          Garmin (GRMN) delivers strong fourth-quarter results on the back of solid performance in fitness, marine, outdoor and aviation segments.

                                            Zacks Equity Research

                                            Why Is PetMed Express (PETS) Down 9.8% Since the Last Earnings Report?

                                            by Zacks Equity Research

                                            PetMed Express (PETS) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

                                              Zacks Equity Research

                                              Ecolab (ECL) Misses Q4 Earnings Estimates, View Impressive

                                              by Zacks Equity Research

                                              Despite strength in Global Industrial and Global Institutional segments, Ecolab (ECL) ended the fourth quarter on an unfavorable note.

                                                Zacks Equity Research

                                                Medtronic (MDT) Beats on Q3 Earnings, Reiterates FY18 View

                                                by Zacks Equity Research

                                                Medtronic (MDT) rides high on strength in all business segments in Q3.

                                                  Tirthankar Chakraborty headshot

                                                  The Zacks Analyst Blog Highlights: Boeing, PetMed, Micron, Healthcare and RH

                                                  by Tirthankar Chakraborty

                                                  The Zacks Analyst Blog Highlights: Boeing, PetMed, Micron, Healthcare and RH